Despite the low tumor mutational burden of renal cell carcinoma (RCC), it has unique immunologic features, including high immune infiltration score and increased infiltration by cytotoxic CD8+ T cells, which are known to be associated with the response to PD-1 blockade [2,3]. The gene discussed is CD8A; the disease is neoplasm.